Angiodynamics (ANGO) Current Deferred Revenue (2012 - 2014)

Angiodynamics' Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $1.5 million for Q1 2014.

• Quarterly Current Deferred Revenue changed N/A year-over-year to $1.5 million in Q1 2014, while the trailing twelve-month figure through Feb 2014 was $1.5 million (changed N/A YoY) and the FY2013 annual result came in at $1.6 million, down 49.87% from the prior year.
• Current Deferred Revenue was $1.5 million for Q1 2014 at Angiodynamics, down from $1.6 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $3.3 million in Q3 2012 and bottomed at $1.5 million in Q1 2014.
• A 3-year average of $2.1 million and a median of $1.6 million in 2013 frame the typical range for Current Deferred Revenue.
• Peak annual rise in Current Deferred Revenue reached 49.87% in 2013, while the deepest fall reached 52.41% in 2013.
• Angiodynamics' Current Deferred Revenue stood at $3.3 million in 2012, then plunged by 51.63% to $1.6 million in 2013, then retreated by 8.97% to $1.5 million in 2014.
• Business Quant data shows ANGO's Current Deferred Revenue at $1.5 million in Q1 2014, $1.6 million in Q4 2013, and $1.6 million in Q3 2013.